Furthermore, hs-cTnT values > 14 ng/l were associated with a doubling in the risk of AMI, stroke, heart failure and all-cause mortality in the BARI 2D trial, a cohort of patients with stable coronary heart disease and type 2 diabetes mellitus [20]. This evidence concerns the gene TNNT2 and diabetes mellitus.